Related Experiment Video
Updated: Jun 21, 2026

06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Distribution of immunochemically defined apoB-containing lipoprotein subclasses in T1D
John Bagdade1, Carolyn Knight-Gibson, Carmen Quiroga
1Department of Medicine, Oregon Health & Sciences University, Portland, OR, United States. john.bagdade@va.gov
Diabetes Research and Clinical Practice
|July 22, 2009
Summary
Young women with type 1 diabetes (T1D) show increased cholesterol-rich Lp-B particles, a potential risk factor for coronary heart disease (CHD) even without typical lipid issues. This highlights a T1D-specific pathway for CHD risk.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Lipid Metabolism
Background:
- Type 1 diabetes (T1D) in young women is associated with coronary heart disease (CHD) risk, independent of traditional lipid risk factors.
- Abnormalities in apolipoprotein B (apoB)-containing lipoprotein subclasses may contribute to this increased cardiovascular risk.
Purpose of the Study:
- To investigate whether specific apoB-containing lipoprotein subclasses are altered in young women with T1D.
- To determine if these lipoprotein abnormalities correlate with glycemic control (HbA1c) and could explain the elevated CHD risk.
Main Methods:
- Immunochemical isolation and quantification of five apoB-containing lipoprotein subclasses.
- Analysis of 37 young, otherwise healthy subjects with T1D (mean age 31.8 years) on conventional insulin therapy.
- Comparison of lipoprotein subclass profiles with healthy controls.
Main Results:
- Women with T1D exhibited significantly higher levels of cholesterol-rich Lp-B particles compared to controls.
- An over-representation of Lp-B particles within the total apoB particle pool was observed in T1D women.
- HbA1c levels strongly correlated with Lp-B particle concentration and apoB subclasses containing apoC-III.
Conclusions:
- A disturbance in Lp-B particle transport, characterized by increased absolute and relative numbers, is present in women with T1D.
- This disturbance may stem from portal hypoinsulinemia and reduced LDL B,E receptor activity.
- These altered lipoprotein dynamics represent a potential mechanism for enhanced CHD risk in T1D women, even with normal LDL and apoB levels.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
